top of page

Advances in Pulmonary Hypertension: Quality of Life

About Advances in Pulmonary Hypertension magazine:


Advances in Pulmonary Hypertension: Official Journal of the Pulmonary Hypertension Association (PHA) is a quarterly publication directed by an editorial board of renowned pulmonary hypertension (PH) experts with oversight by PHA's Scientific Leadership Council.


Its mission is to assist physicians in their clinical decision-making by informing them of important trends affecting their practice and providing an analysis of the impact of new findings in peer-reviewed publications. Issue themes are independently selected by the Editorial Board after an analysis of newly released data and practice gaps. A guest editor invites thought leaders in the selected topic area to author reviews of these timely subject. Each article is finally reviewed and approved by members of the Editorial Board.


 
 
 

Recent Posts

Promising results for drug candidate CS1

This press release reports that over the 12 months of their Expanded Access Program enrolling ten patients, the majority of patients with pulmonary arterial hypertension who completed treatment with d

 
 
 
Using sotatercept off-label in children

Clinical trials for sotatercept didn't include children, so any pediatric use is off-label. This study, conducted at one children's hospital in San Diego, evaluated sotatercept in 7 pediatric patients

 
 
 

Comments


PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page